| ProAmatine |
FDA approval of ProAmatine for the treatment of orthostatic hypotension is awaiting receipt and review of further data to be provided by Roberts Pharmaceutical Corporation. Source: PRNewswire, 03/26/96.
Ãâó: www.mtdaily.com/mt1/news/n033196.html
|
|---|